Rare Disease Genetic Testing Global Market Report 2025

Description

Rare disease genetic testing involves analyzing an individual's DNA to identify genetic mutations or variations that may cause or contribute to a rare disease. This testing enables accurate diagnosis, early intervention, and personalized treatment planning for patients with rare or undiagnosed conditions.

The primary disease types addressed by rare disease genetic testing include immunological disorders, cardiovascular disorders, neurological diseases, endocrine and metabolic disorders, hematological diseases, dermatological diseases, and others. Immunological disorders involve abnormal immune system function, which may manifest as overactivity, underactivity, or autoimmunity. These conditions are diagnosed using technologies such as next-generation sequencing, Sanger sequencing, polymerase chain reaction (PCR)-based testing, array-based testing, fluorescence in situ hybridization (FISH), and others. In terms of specialty testing, rare disease genetic testing is classified into molecular genetic tests, chromosomal genetic tests, and biochemical genetic tests, serving a diverse range of end users, including hospitals and clinics, research laboratories and contract research organizations (CROs), diagnostic laboratories, and other healthcare providers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The rare disease genetic testing market research report is one of a series of new reports from The Business Research Company that provides rare disease genetic testing market statistics, including rare disease genetic testing industry global market size, regional shares, competitors with a rare disease genetic testing market share, detailed rare disease genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the rare disease genetic testing industry. This rare disease genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rare disease genetic testing market size has grown rapidly in recent years. It will grow from $1.03 billion in 2024 to $1.17 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to increasing awareness of rare genetic disorders, rising demand for early and accurate diagnosis, growing government funding for rare disease research, expanding availability of genetic testing services, increased investments in precision medicine, and a rising incidence of rare genetic conditions.

The rare disease genetic testing market size is expected to see rapid growth in the next few years. It will grow to $1.93 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to increasing adoption of next-generation sequencing, rising focus on personalized medicine, growing investments in genetic research, expanding healthcare infrastructure in emerging markets, rising demand for diagnostic testing, increased hereditary cancer testing, and growing preference for non-invasive diagnostic solutions. Major trends in the forecast period include advancements in genome editing technologies, development of advanced bioinformatics tools for genetic data analysis, innovation in multi-gene panel testing, progress in portable genetic testing devices, and improvements in sample collection techniques.

The rising prevalence of genetic disorders is driving growth in the rare disease genetic testing market. Genetic disorders arise from DNA abnormalities, either inherited from one or both parents or caused by new mutations. Factors such as increasing parental age contribute to a higher likelihood of passing on genetic mutations. Rare disease genetic testing enables early and accurate detection of these conditions, supporting personalized treatment planning and improving patient outcomes. For example, in May 2024, the UK National Health Service reported that 17,000 people were living with sickle cell disease, an inherited genetic blood disorder, with approximately 250 new cases diagnosed each year, highlighting the ongoing need for genetic testing.

Key players are developing digital genomics platforms to enhance the speed, accuracy, and scalability of rare disease diagnosis. These platforms integrate genomic data analysis, interpretation, and reporting to streamline testing workflows. In March 2025, Strand Life Sciences Private Limited (India) launched the StrandOmics Portal, a digital genomics platform that provides clinicians with detailed insights into genetic variants, enabling faster and more precise diagnoses. The platform supports advanced variant interpretation, including prenatal diagnostics, and allows independent review of genetic data, reinforcing precision medicine efforts.

In January 2022, Exact Sciences Corporation (US) acquired Prevention Genetics LLC for \$190 million to expand its hereditary cancer testing capabilities. This acquisition strengthens Exact Sciences' genetic testing portfolio, accelerating access to hereditary cancer diagnostics and providing healthcare providers with more comprehensive genetic insights. Prevention Genetics specializes in rare disease diagnostics, complementing Exact Sciences' focus on precision medicine.

Major players in the rare disease genetic testing market are Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Natera Inc., OPKO Health Inc., Myriad Genetics Inc., Fulgent Genetics Inc., BioReference Laboratories Inc., Invitae Corporation, Ambry Genetics Corporation, Centogene N.V., Baylor Genetics Company, PreventionGenetics, Blueprint Genetics Oy, Realm IDX Inc., Artemis DNA Inc., BGI Genomics Co. Ltd.

North America was the largest region in the rare disease genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in rare disease genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the rare disease genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rare disease genetic testing market consists of revenues earned by entities by providing services such as whole exome sequencing, targeted gene panel testing, whole genome sequencing, carrier screening, and newborn genetic screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The rare disease genetic testing market also includes sales of genetic testing kits, bioinformatics software, next-generation sequencing (NGS) platforms, laboratory reagents and consumables, and targeted gene panels. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rare Disease Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rare disease genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rare disease genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rare disease genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Disease Type: Immunological Disorders; Cardiovascular Disorders; Neurological Disease; Endocrine And Metabolism Disorders Diseases; Hematological Diseases; Dermatological Disease; Other Disease Types
2) By Technology: Next-Generation Sequencing; Sanger Sequencing; Polymerase Chain Reaction Based Testing; Array Based Testing; Fluorescence In Situ Hybridization; Other Technologies
3) By Specialty: Molecular Genetic Tests; Chromosomal Genetic Tests; Biochemical Genetic Tests
4) By End-User: Hospitals And Clinics; Research Laboratories And Contract Research Organizations; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Immunological Disorders: Autoimmune Disorders; Allergic Conditions; Primary Immunodeficiency Disorders; Inflammatory Disorders
2) By Cardiovascular Disorders: Congenital Heart Defects; Cardiomyopathies; Aortic Aneurysms; Pulmonary Hypertension
3) By Neurological Disease: Neurodegenerative Disorders; Neuromuscular Disorders; Epileptic Syndromes; Movement Disorders
4) By Endocrine And Metabolism Disorders Diseases: Inherited Metabolic Disorders; Thyroid Disorders; Adrenal Disorders; Diabetes Related Genetic Conditions
5) By Hematological Diseases: Hemophilia; Thalassemia; Sickle Cell Disease; Clotting Disorders
6) By Dermatological Disease: Genetic Skin Disorders; Connective Tissue Disorders; Pigmentary Disorders; Keratinization Disorders
7) By Other Disease Types: Skeletal Dysplasia; Renal Genetic Disorders; Ophthalmic Genetic Conditions; Gastrointestinal Genetic Conditions
Companies Mentioned: Thermo Fisher Scientific Inc.; Quest Diagnostics Inc.; Eurofins Scientific SE; Agilent Technologies Inc.; Illumina Inc.; QIAGEN N.V.; Natera Inc.; OPKO Health Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; BioReference Laboratories Inc.; Invitae Corporation; Ambry Genetics Corporation; Centogene N.V.; Baylor Genetics Company; PreventionGenetics; Blueprint Genetics Oy; Realm IDX Inc.; Artemis DNA Inc.; BGI Genomics Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37875

1. Executive Summary

2. Rare Disease Genetic Testing Market Characteristics

3. Rare Disease Genetic Testing Market Trends And Strategies

4. Rare Disease Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Rare Disease Genetic Testing Growth Analysis And Strategic Analysis Framework

5.1. Global Rare Disease Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Rare Disease Genetic Testing Market Growth Rate Analysis
5.4. Global Rare Disease Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Rare Disease Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Rare Disease Genetic Testing Total Addressable Market (TAM)

6. Rare Disease Genetic Testing Market Segmentation

6.1. Global Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunological Disorders
Cardiovascular Disorders
Neurological Disease
Endocrine And Metabolism Disorders Diseases
Hematological Diseases
Dermatological Disease
Other Disease Types
6.2. Global Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Next-Generation Sequencing
Sanger Sequencing
Polymerase Chain Reaction Based Testing
Array Based Testing
Fluorescence In Situ Hybridization
Other Technologies
6.3. Global Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Molecular Genetic Tests
Chromosomal Genetic Tests
Biochemical Genetic Tests
6.4. Global Rare Disease Genetic Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Research Laboratories And Contract Research Organizations
Diagnostic Laboratories
Other End Users
6.5. Global Rare Disease Genetic Testing Market, Sub-Segmentation Of Immunological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autoimmune Disorders
Allergic Conditions
Primary Immunodeficiency Disorders
Inflammatory Disorders
6.6. Global Rare Disease Genetic Testing Market, Sub-Segmentation Of Cardiovascular Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Congenital Heart Defects
Cardiomyopathies
Aortic Aneurysms
Pulmonary Hypertension
6.7. Global Rare Disease Genetic Testing Market, Sub-Segmentation Of Neurological Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Neurodegenerative Disorders
Neuromuscular Disorders
Epileptic Syndromes
Movement Disorders
6.8. Global Rare Disease Genetic Testing Market, Sub-Segmentation Of Neurological Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Neurodegenerative Disorders
Neuromuscular Disorders
Epileptic Syndromes
Movement Disorders
6.9. Global Rare Disease Genetic Testing Market, Sub-Segmentation Of Endocrine And Metabolism Disorders Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inherited Metabolic Disorders
Thyroid Disorders
Adrenal Disorders
Diabetes Related Genetic Conditions
6.10. Global Rare Disease Genetic Testing Market, Sub-Segmentation Of Dermatological Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Skin Disorders
Connective Tissue Disorders
Pigmentary Disorders
Keratinization Disorders
6.11. Global Rare Disease Genetic Testing Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Skeletal Dysplasias
Renal Genetic Disorders
Ophthalmic Genetic Conditions
Gastrointestinal Genetic Conditions

7. Rare Disease Genetic Testing Market Regional And Country Analysis

7.1. Global Rare Disease Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Rare Disease Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Rare Disease Genetic Testing Market

8.1. Asia-Pacific Rare Disease Genetic Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Rare Disease Genetic Testing Market

9.1. China Rare Disease Genetic Testing Market Overview
9.2. China Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Rare Disease Genetic Testing Market

10.1. India Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Rare Disease Genetic Testing Market

11.1. Japan Rare Disease Genetic Testing Market Overview
11.2. Japan Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Rare Disease Genetic Testing Market

12.1. Australia Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Rare Disease Genetic Testing Market

13.1. Indonesia Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Rare Disease Genetic Testing Market

14.1. South Korea Rare Disease Genetic Testing Market Overview
14.2. South Korea Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Rare Disease Genetic Testing Market

15.1. Western Europe Rare Disease Genetic Testing Market Overview
15.2. Western Europe Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Rare Disease Genetic Testing Market

16.1. UK Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Rare Disease Genetic Testing Market

17.1. Germany Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Rare Disease Genetic Testing Market

18.1. France Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Rare Disease Genetic Testing Market

19.1. Italy Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Rare Disease Genetic Testing Market

20.1. Spain Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Rare Disease Genetic Testing Market

21.1. Eastern Europe Rare Disease Genetic Testing Market Overview
21.2. Eastern Europe Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Rare Disease Genetic Testing Market

22.1. Russia Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Rare Disease Genetic Testing Market

23.1. North America Rare Disease Genetic Testing Market Overview
23.2. North America Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Rare Disease Genetic Testing Market

24.1. USA Rare Disease Genetic Testing Market Overview
24.2. USA Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Rare Disease Genetic Testing Market

25.1. Canada Rare Disease Genetic Testing Market Overview
25.2. Canada Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Rare Disease Genetic Testing Market

26.1. South America Rare Disease Genetic Testing Market Overview
26.2. South America Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Rare Disease Genetic Testing Market

27.1. Brazil Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Rare Disease Genetic Testing Market

28.1. Middle East Rare Disease Genetic Testing Market Overview
28.2. Middle East Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Rare Disease Genetic Testing Market

29.1. Africa Rare Disease Genetic Testing Market Overview
29.2. Africa Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Rare Disease Genetic Testing Market Competitive Landscape And Company Profiles

30.1. Rare Disease Genetic Testing Market Competitive Landscape
30.2. Rare Disease Genetic Testing Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Rare Disease Genetic Testing Market Other Major And Innovative Companies

31.1. QIAGEN N.V.
31.2. Natera Inc.
31.3. OPKO Health Inc.
31.4. Myriad Genetics Inc.
31.5. Fulgent Genetics Inc.
31.6. BioReference Laboratories Inc.
31.7. Invitae Corporation
31.8. Ambry Genetics Corporation
31.9. Centogene N.V.
31.10. Baylor Genetics Company
31.11. PreventionGenetics
31.12. Blueprint Genetics Oy
31.13. Realm IDX Inc.
31.14. Artemis DNA Inc.
31.15. BGI Genomics Co. Ltd.

32. Global Rare Disease Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rare Disease Genetic Testing Market

34. Recent Developments In The Rare Disease Genetic Testing Market

35. Rare Disease Genetic Testing Market High Potential Countries, Segments and Strategies

35.1 Rare Disease Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
35.2 Rare Disease Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
35.3 Rare Disease Genetic Testing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer